GlucoTrack unit Lokahi Therapeutics expands ai2 Futures Lab to 12 university partnerships

Reuters2026/07/31 12:01

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

GlucoTrack’s wholly owned subsidiary Lōkahi Therapeutics expanded its ai² Futures Lab pipeline-sourcing program focused on shelved or under-prioritized drug assets.
First-year output: more than 45 late-stage therapeutic opportunities screened on a budget of about USD 33,000.
Five opportunities moved into active company discussions; evaluated assets represented more than USD 500 million in prior biopharma investment.
Program scale-up targets 12 university collaborations for the 2026-2027 academic year, up from six, with 100% retention of inaugural partners.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. GlucoTrack Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20260731301672) on July 31, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

GlucoTrack unit Lokahi Therapeutics expands ai2 Futures Lab to 12 university partnerships

You may also like

Crypto prices